DaVita Posts Strong Q4 Earnings, Fueling Investor Optimism Amid Healthcare Sector Scrutiny
DaVita Inc. (NYSE: DVA) reported fourth-quarter revenue and profit that surpassed analyst forecasts, driven by strategic pricing and operational efficiency. The results sent shares sharply higher as the dialysis giant navigates a complex regulatory and demographic landscape.